unknown
Stage
1
Investors
About
Codiak develops extracellular vesicle-based therapeutics for targeted drug delivery and treatment of complex diseases.
Explore Codiak's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.